Cargando…
Histone Deacetylase 6 as a Therapeutic Target in B cell-associated Hematological Malignancies
B lymphocytes play a critical role in humoral immunity. Abnormal B cell development and function cause a variety of hematological malignancies such as myeloma, B cell lymphoma, and leukemia. Histone deacetylase 6 (HDAC6) inhibitors alone or in combination with other drugs have shown efficacy in seve...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333221/ https://www.ncbi.nlm.nih.gov/pubmed/32676030 http://dx.doi.org/10.3389/fphar.2020.00971 |